Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We will conduct a single-center retrospective study at a university hospital. A total of 3,385 gastroscopic white-light images from patients with pathologically confirmed findings will be analyzed. The AI software will automatically identify images as non-neoplastic or neoplastic (low-grade dysplasia, high-grade dysplasia, early gastric cancer with mucosal or submucosal invasion, or advanced gastric cancer) and highlighted lesion locations. Two experienced endoscopists will independently review the same image set without AI assistance for comparison. Primary outcomes are sensitivity and specificity of the AI in detecting gastric neoplasms (by category and overall), and the localization accuracy measured by the localization receiver operating characteristic (LROC) curve area. Secondary outcomes is includes comparison of the AI's diagnostic performance with that of endoscopists.
We will conduct a single-center retrospective study at a university hospital. A total of 3,385 gastroscopic white-light images from patients with pathologically confirmed findings will be analyzed. The AI software will automatically identify images as non-neoplastic or neoplastic (low-grade dysplasia, high-grade dysplasia, early gastric cancer with mucosal or submucosal invasion, or advanced gastric cancer) and highlighted lesion locations. Two experienced endoscopists will independently review the same image set without AI assistance for comparison. Primary outcomes are sensitivity and specificity of the AI in detecting gastric neoplasms (by category and overall), and the localization accuracy measured by the localization receiver operating characteristic (LROC) curve area. Secondary outcomes is includes comparison of the AI's diagnostic performance with that of endoscopists.
Inclusion criteria:
Age 19 or older At least one gastric lesion biopsied with a definitive pathological diagnosis Availability of high-quality white-light endoscopy images of the lesion and surrounding mucosa
Exclusion criteria:
Poor-quality images (e.g., out of focus or obscured) Lack of histopathological confirmation of the lesion
Each image will be paired with a reference standard diagnosis based on the pathology result for that lesion or region.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| AI performance | sensitivity and specificity of the AI in detecting gastric neoplasms (by category and overall), and the localization accuracy measured by the localization receiver operating characteristic (LROC) curve area. | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| comparison of the AI's diagnostic performance with that of endoscopists. | Secondary outcomes included comparison of the AI's diagnostic performance with that of endoscopists. (sensitivity and specificity of the AI in detecting gastric neoplasms (by category and overall), and the localization accuracy measured by the localization receiver operating characteristic (LROC) curve area.) | Day 1 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
A total of 3,385 endoscopic images were collected from patients who underwent gastroscopy at our institution (Chuncheon Sacred Heart Hospital from 2010 to 2017) and had adequate reference standards. Images were selected to include both neoplastic lesions and non-neoplastic findings. Inclusion criteria were images of gastric lesions that had definitive histopathology diagnoses (from endoscopic biopsy or resection) of one of five severity categories: LGD, HGD, EGC-M (mucosal early gastric carcinoma), EGC-SM (submucosal invasive early carcinoma), or AGC (advanced gastric cancer). Additionally, a set of non-neoplastic images (normal or benign findings with negative biopsies) was included as controls.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Chang Seok Bang, MD, PhD | HALLYM UNIVERSITY COLLEGE OF MEDICINE, Korea | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chuncheon Sacred Heart hospital | Chuncheon | Gangwon-do | 24253 | South Korea |
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013274 | Stomach Neoplasms |
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D013272 | Stomach Diseases |
Not provided
Not provided